Can-Fite BioPharma Ltd.
AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT

Last updated:

Abstract:

Provided is an A3 adenosine receptor (A.sub.3AR) ligand for use in achieving at least one fat loss effect selected from: reducing weight of the subject; reducing body fat mass in the subject; treating obesity in the subject and inhibiting adipocytes proliferation in a subject. The disclosure also concerns pharmaceutical compositions, methods of treatment and kits comprising the A.sub.3AR ligand.

Status:
Application
Type:

Utility

Filling date:

5 Jan 2020

Issue date:

17 Mar 2022